Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Baiyunshan Pharmaceutical has a broad commercial portfolio of over-the-counter and prescription drugs including antibiotics, generics like sildenafil citrate (“JinGe”), memantine hydrochloride for dementia/Alzheimer’s disease, as well as innovative programs in oncology such as second-generation Trk inhibitors for NTRK fusion-positive cancers. The company also develops novel cephalosporins and maintains a strong presence in both traditional Chinese medicine and modern pharmaceuticals. Several drugs are approved or in late-stage clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Baiyunshan.